Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Jun 27

PMID 38931455

Authors

Nikita Navolokin

Viktoria Adushkina

Daria Zlatogorskaya

Valeria Telnova

Arina Evsiukova

Elena Vodovozova

Anna Eroshova

Elina Dosadina

Sergey Diduk

Oxana Semyachkina-Glushkovskaya

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic, caused by infection with the SARS-CoV-2 virus, is associated with cognitive impairment and Alzheimer's disease (AD) progression. Once it enters the brain, the SARS-CoV-2 virus stimulates accumulation of amyloids in the brain that are highly toxic to neural cells. These amyloids may trigger neurological symptoms in COVID-19. The meningeal lymphatic vessels (MLVs) play an important role in removal of toxins and mediate viral drainage from the brain. MLVs are considered a promising target to prevent COVID-19-exacerbated dementia. However, there are limited methods for augmentation of MLV function. This review highlights new discoveries in the field of COVID-19-mediated amyloid accumulation in the brain associated with the neurological symptoms and the development of promising strategies to stimulate clearance of amyloids from the brain through lymphatic and other pathways. These strategies are based on innovative methods of treating brain dysfunction induced by COVID-19 infection, including the use of photobiomodulation, plasmalogens, and medicinal herbs, which offer hope for addressing the challenges posed by the SARS-CoV-2 virus.

Citing Articles

Plasmalogens Improve Lymphatic Clearance of Amyloid Beta from Mouse Brain and Cognitive Functions.

Shirokov A, Zlatogosrkaya D, Adushkina V, Vodovozova E, Kardashevskaya K, Sultanov R Int J Mol Sci. 2024; 25(23).

PMID: 39684263 PMC: 11640916. DOI: 10.3390/ijms252312552.

Determination of Plasmalogen Molecular Species in Hen Eggs.

Miyazawa T, Higuchi O, Sogame R, Miyazawa T Molecules. 2024; 29(20).

PMID: 39459164 PMC: 11510340. DOI: 10.3390/molecules29204795.

Long-term cognitive change after COVID-19 in older individuals.

Nat Aging. 2024; 4(9):1180-1181.

PMID: 39044034 DOI: 10.1038/s43587-024-00687-z.

References

Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T . Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019; 29(10):787-803. PMC: 6796854. DOI: 10.1038/s41422-019-0216-x. View

Shahbaz M, Kuivanen S, Lampinen R, Mussalo L, Hron T, Zavodna T . Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa. J Neuroinflammation. 2023; 20(1):299. PMC: 10722731. DOI: 10.1186/s12974-023-02979-4. View

Priyal , Sehgal V, Kapila S, Taneja R, Mehmi P, Gulati N . Review of Neurological Manifestations of SARS-CoV-2. Cureus. 2023; 15(4):e38194. PMC: 10223874. DOI: 10.7759/cureus.38194. View

Bourgade K, Dupuis G, Frost E, Fulop T . Anti-Viral Properties of Amyloid-β Peptides. J Alzheimers Dis. 2016; 54(3):859-878. DOI: 10.3233/JAD-160517. View

Silva T, Reis J, Teixeira J, Borges F . Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes. Ageing Res Rev. 2014; 15:116-45. DOI: 10.1016/j.arr.2014.03.008. View

The Lancet . Lecanemab for Alzheimer's disease: tempering hype and hope. Lancet. 2022; 400(10367):1899. DOI: 10.1016/S0140-6736(22)02480-1. View

Senanayake V, Goodenowe D . Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?. Alzheimers Dement (N Y). 2019; 5:524-532. PMC: 6804645. DOI: 10.1016/j.trci.2019.08.003. View

Hatab H, Abdel Hamid F, Soliman A, Al-Shafie T, Ismail Y, El-Houseini M . A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study. J Gastrointest Oncol. 2019; 10(4):766-776. PMC: 6657326. DOI: 10.21037/jgo.2019.03.07. View

Ding X, Wang X, Xia D, Liu H, Tian H, Fu Y . Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson's disease. Nat Med. 2021; 27(3):411-418. DOI: 10.1038/s41591-020-01198-1. View

10.

Abavisani M, Rahimian K, Mahdavi B, Tokhanbigli S, Mollapour Siasakht M, Farhadi A . Mutations in SARS-CoV-2 structural proteins: a global analysis. Virol J. 2022; 19(1):220. PMC: 9759450. DOI: 10.1186/s12985-022-01951-7. View

11.

Zanza C, Romenskaya T, Manetti A, Franceschi F, La Russa R, Bertozzi G . Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina (Kaunas). 2022; 58(2). PMC: 8876409. DOI: 10.3390/medicina58020144. View

12.

Rudnicka-Drozak E, Drozak P, Mizerski G, Zaborowski T, Slusarska B, Nowicki G . Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?. Int J Environ Res Public Health. 2023; 20(3). PMC: 9915236. DOI: 10.3390/ijerph20032146. View

13.

Youssef M, Ibrahim A, Akashi K, Hossain M . PUFA-Plasmalogens Attenuate the LPS-Induced Nitric Oxide Production by Inhibiting the NF-kB, p38 MAPK and JNK Pathways in Microglial Cells. Neuroscience. 2018; 397:18-30. DOI: 10.1016/j.neuroscience.2018.11.030. View

14.

Hamblin M . Photobiomodulation for Alzheimer's Disease: Has the Light Dawned?. Photonics. 2019; 6(3). PMC: 6664299. DOI: 10.3390/photonics6030077. View

15.

Sejimo S, Hossain M, Akashi K . Scallop-derived plasmalogens attenuate the activation of PKCδ associated with the brain inflammation. Biochem Biophys Res Commun. 2018; 503(2):837-842. DOI: 10.1016/j.bbrc.2018.06.084. View

16.

Crunfli F, Carregari V, Veras F, Silva L, Nogueira M, Antunes A . Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022; 119(35):e2200960119. PMC: 9436354. DOI: 10.1073/pnas.2200960119. View

17.

Semyachkina-Glushkovskaya O, Abdurashitov A, Dubrovsky A, Klimova M, Agranovich I, Terskov A . Photobiomodulation of lymphatic drainage and clearance: perspective strategy for augmentation of meningeal lymphatic functions. Biomed Opt Express. 2020; 11(2):725-734. PMC: 7041454. DOI: 10.1364/BOE.383390. View

18.

Niklasson B, Lindquist L, Klitz W, Englund E . Picornavirus Identified in Alzheimer's Disease Brains: A Pathogenic Path?. J Alzheimers Dis Rep. 2020; 4(1):141-146. PMC: 7306919. DOI: 10.3233/ADR-200174. View

19.

Horner S, Berger L, Gibas K . Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report. Photodiagnosis Photodyn Ther. 2020; 30:101777. DOI: 10.1016/j.pdpdt.2020.101777. View

20.

Li W, Chen R, Yang L, Huang T, Xu Q, Mi S . Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio. Eur J Drug Metab Pharmacokinet. 2011; 37(1):39-44. DOI: 10.1007/s13318-011-0058-5. View